295 related articles for article (PubMed ID: 30234458)
41. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
[TBL] [Abstract][Full Text] [Related]
42. A feasibility study: Selection of a personalized radiotherapy fractionation schedule using spatiotemporal optimization.
Kim M; Stewart RD; Phillips MH
Med Phys; 2015 Nov; 42(11):6671-8. PubMed ID: 26520757
[TBL] [Abstract][Full Text] [Related]
43. Comparison of radiation-induced normal lung tissue density changes for patients from multiple institutions receiving conventional or hypofractionated treatments.
Diot Q; Marks LB; Bentzen SM; Senan S; Kavanagh BD; Lawrence MV; Miften M; Palma DA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):626-32. PubMed ID: 24929168
[TBL] [Abstract][Full Text] [Related]
44. Dose-per-fraction escalation of accelerated hypofractionated three-dimensional conformal radiotherapy in locally advanced non-small cell lung cancer.
Kepka L; Tyc-Szczepaniak D; Bujko K
J Thorac Oncol; 2009 Jul; 4(7):853-61. PubMed ID: 19487965
[TBL] [Abstract][Full Text] [Related]
45. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
46. Acute histopathological responses of testicular tissues after different fractionated abdominal irradiation in rats.
Akdere H; Yurut Caloglu V; Tastekin E; Caloglu M; Turkkan G; Mericliler M; Mehmet Burgazli K
Postgrad Med; 2015 Jan; 127(1):73-7. PubMed ID: 25526226
[TBL] [Abstract][Full Text] [Related]
47. The radiobiology of hypofractionation.
Nahum AE
Clin Oncol (R Coll Radiol); 2015 May; 27(5):260-9. PubMed ID: 25797579
[TBL] [Abstract][Full Text] [Related]
48. Impact of fraction size on lung radiation toxicity: hypofractionation may be beneficial in dose escalation of radiotherapy for lung cancers.
Jin JY; Kong FM; Chetty IJ; Ajlouni M; Ryu S; Ten Haken R; Movsas B
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):782-8. PubMed ID: 19577855
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer.
McDonald AM; Jacob R; Dobelbower MC; Kim RY; Fiveash JB
Acta Oncol; 2013 Aug; 52(6):1181-8. PubMed ID: 23544356
[TBL] [Abstract][Full Text] [Related]
50. Optimal fractionation in radiotherapy for non-small cell lung cancer--a modelling approach.
Lindblom E; Dasu A; Toma-Dasu I
Acta Oncol; 2015; 54(9):1592-8. PubMed ID: 26217986
[TBL] [Abstract][Full Text] [Related]
51. Comparative radiobiological analysis and preliminary results of Ultra hypofractionated accelerated radiotherapy for low-risk prostate cancer patients.
Nanos C; Souftas V; Zisimopoulos A; Abatzoglou I; Koukourakis MI
J BUON; 2021; 26(3):956-963. PubMed ID: 34268959
[TBL] [Abstract][Full Text] [Related]
52. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Aluwini S; Pos F; Schimmel E; Krol S; van der Toorn PP; de Jager H; Alemayehu WG; Heemsbergen W; Heijmen B; Incrocci L
Lancet Oncol; 2016 Apr; 17(4):464-474. PubMed ID: 26968359
[TBL] [Abstract][Full Text] [Related]
53. From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer.
Jeremić B; Milicić B
Cancer; 2008 Feb; 112(4):876-84. PubMed ID: 18172901
[TBL] [Abstract][Full Text] [Related]
54. Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer.
Faria SL; Souhami L; Portelance L; Duclos M; Vuong T; Small D; Freeman CR
Radiat Oncol; 2006 Nov; 1():42. PubMed ID: 17078878
[TBL] [Abstract][Full Text] [Related]
55. Hypofractionation: what does it mean for prostate cancer treatment?
Liao Y; Joiner M; Huang Y; Burmeister J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):260-8. PubMed ID: 19879698
[TBL] [Abstract][Full Text] [Related]
56. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study.
Onishi H; Shirato H; Nagata Y; Hiraoka M; Fujino M; Gomi K; Niibe Y; Karasawa K; Hayakawa K; Takai Y; Kimura T; Takeda A; Ouchi A; Hareyama M; Kokubo M; Hara R; Itami J; Yamada K; Araki T
J Thorac Oncol; 2007 Jul; 2(7 Suppl 3):S94-100. PubMed ID: 17603311
[TBL] [Abstract][Full Text] [Related]
57. Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis.
Ruggieri R; Stavrev P; Naccarato S; Stavreva N; Alongi F; Nahum AE
Phys Med; 2017 Dec; 44():188-195. PubMed ID: 28130055
[TBL] [Abstract][Full Text] [Related]
58. Impact of Prolonged Fraction Delivery Time Modelling Stereotactic Body Radiation Therapy with High Dose Hypofractionation on the Killing of Cultured ACHN Renal Cell Carcinoma Cell Line.
Khorramizadeh M; Saberi A; Tahmasebi-Birgani M; Shokrani P; Amouhedari A
J Biomed Phys Eng; 2017 Sep; 7(3):205-216. PubMed ID: 29082212
[TBL] [Abstract][Full Text] [Related]
59. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.
Stuschke M; Budach V; Stüben G; Streffer C; Sack H
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182
[TBL] [Abstract][Full Text] [Related]
60. Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells.
Gupta S; Koru-Sengul T; Arnold SM; Devi GR; Mohiuddin M; Ahmed MM
Mol Cancer Ther; 2011 Feb; 10(2):292-302. PubMed ID: 21216938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
